title: Why So Few New Cardiovascular Drugs Translate to the Clinics.
authors: From the Department of Cell Biology and Molecular Medicine, Rutgers-New Jersey Medical School, Newark. vatnersf@njms.rutgers.edu.
authors: Stephen F
authors: SF
authors: Vatner
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D013045:Species Specificity; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends*
chemical_list: D002317:Cardiovascular Agents; D015507:Drugs, Investigational
keywords: academic fraud; cardiovascular physiology; pharmacology